Antimicrobial activities of bacteriocins E 50-52 and B 602 against antibiotic-resistant strains involved in nosocomial infections

Probiotics and Antimicrobial Proteins

Volumn 1, Issue 2, 2009, Pages 136-142

  Svetoch, E A ^a   Eruslanov, B V ^a   Kovalev, Y N ^a   Mitsevich, E V ^a   Mitsevich, I P ^a   Levchuk, V P ^a   Fursova, N K ^a   Perelygin, V V ^a   Stepanshin, Y G ^a   Teymurasov, M G ^a   Seal, B S ^b   Stern, N J ^b  

^a State Research Center for Applied Microbiology and Biotechnology SRCAMB   (Russian Federation)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Antibacterial therapy; Bacteriocin; ESBL; MICs; MRSA; Nosocomial infection

Indexed keywords

EID: 79955613107     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-009-9027-6     Document Type: Article

References (24)

1. Lee JH, Jeong SK, Cha S-S, Lee SH (2009) New disturbing trend in antimicrobial resistance of Gram-negative pathogens. PLoS Pathog 5(3):e1000221. doi:10.1371/journal.ppat.1000221
2. Roberts L, Simpson S (2008) Deadly defiance. Science 321:355
3. Svetoch EA, Stern NJ, Eruslanov BV et al (2005) Isolation of Bacillus circulans and Paenibacillus polymyxa strains inhibitory to Campylobacter jejuni and characterization of associated bacteriocins. J Food Prot 68:11-17
4. Svetoch EA, Eruslanov BV, Perelygin VV et al (2008) Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin. J Agric Food Chem 56:1942-1948
5. Fursova NK, Kruglov AN, Abaev IV, Kovalev YN, Pecherskikh EI, Astashkin EI, Pachkunov DM, Pryamchuk SD, Anisimova VA, Mitzevich ME (2006) Spreading of beta-lactamase genes among nosocomial isolates collected from Moscow clinics. CMI 12(Suppl 4):P1351
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility tests (2000) 7th ed. Approved standard. NCCLS document M2-A7, vol 20, issue 1, Wayne, PA
7. Drider D, Fimland G, Héchard Y, McMullen LM, Prévost H (2006) The continuing story of class IIa bacteriocins. Microbiol Mol Biol Rev 70(2):564-582
8. Cleveland J, Montville TJ, Nes IF, Chikindas ML (2001) Bacteriocins: safe natural antimicrobials for food preservation. Int J Food Microbiol 71:1-20
9. Ingham AB, Ford M, Moore RJ, Tizard M (2003) The bacteriocin piscicolin 126 retains antilisterial activity in vivo. J Antimicrob Chemother 51:1365-1371
10. Wachsman MB, Castilla V, de Ruiz Holgado AP, de Torres RA, Sesma F, Coto CE (2003) Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro. Antivir Res 58:17-24
11. Nissen-Meyer J, Hauge HH, Fimland G, Eijsink VGH, Nes IF (2001) Ribosomally synthesized antimicrobial peptides by lactic acid bacteria: their function, structure, biogenesis, and their mechanism of action. Recent Res Dev Microbiol 1:141-154
12. Sprules T, Kawulka KE, Vederas JC (2004) NMR solution structure of ImB2, a protein conferring immunity to antimicrobial activity of the type IIa bacteriocin, carnobacteriocin B2. Biochemistry 43:11740-11749
13. Giacometti A, Cirioni O, Barchiesi F, Fortuna M, Scalise G (1999) In vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J Antimicrob Chemother 44:641-645
14. Brumfitt W, Salton MRJ, Hamilton-Miller JMT (2002) Nisin, alone and combined with peptidoglycan-moduling antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J Antimicrobiol Chemother 50: 731-734
15. Tahiri I, Desbiens M, Benech R, Kheadr E, Lacroix C, Thibault S, Ouellet D, Fliss I (2004) Purification, characterization and amino acid sequencing of divergicin M35: a novel class IIa bacteriocin produced by Carnobacterium divergens M35. Int J Food Microbiol 97(2):123-136
16. Piper C, Draper LA, Cotter PD, Ross PR, Hill C (2009) A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother 64:546-551
17. Gravesen A, Sørensen K, Aarestrup FM, Knøchel S (2007) Spontaneous nisin-resistant Listeria monocytogenes mutants with increased expression of a putative penicillin-binding protein and their sensitivity to various antibiotics. Microb Drug Resist 7(2): 127-135
18. Swe PM, Cook GM, Tagg JR, Jack RW (2009) Mode of action of dysgalacticin: a large heat-labile bacteriocin. J Antimicrob Chemother 63:679-686
19. Sosunov V, Mischenko V, Eruslanov B et al (2007) Antimycobacterial activity of bacteriocins and their complexes with liposmes. J Antimicrob Chemother 59:919-925
20. Line JE, Svetoch EA, Eruslanov BV et al (2008) Isolation and purification of enterocin E-760 with broad antimicrobial activity against Gram-positive and Gram-negative bacteria. Antimicrob Agents Chemother 52:1094-1100
21. Stern NJ, Svetoch EA, Eruslanov BV et al (2005) Paenibacillus polymyxa purified bacteriocin to control Campylobacter jejuni in chickens. J Food Prot 68:1450-1453
22. Stern NJ, Svetoch EA, Eruslanov BV et al (2006) Isolation of a Lactobacillus salivarius and purification of its bacteriocin that is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system. Antimicrob Agents Chemo 50:3111-3116
23. Stern N, Eruslanov BV, Pokhilenko V et al (2008) Bacteriocins reduce Campylobacter jejuni colonization while bacteria producing bacteriocins are ineffective. Microbial Ecol Hlth Dis 20:74-79
24. Svetoch EA, Levchuk VP, Pokhilenko VD et al (2008) Inactivating methicillin resistant Staphylococcus aureus (MRSA) and other pathogens by bacteriocins OR-7 and E 50-52. J Clin Microbiol 46:3863-3865